Carole Ho insider trades

Open-market stock purchases and sales by Carole Ho, Director at Royalty Pharma plc, from SEC Form 4 filings since Feb 26, 2018.

Recent trades

DateStockTradeValue
Jun 5, 2026RPRX Royalty Pharma plcBought (not open market)—

Companies traded

  • RPRX Royalty Pharma plc: other filings, last Jun 5, 2026
  • DNLI Denali Therapeutics Inc: 115 sales, last Aug 13, 2025
  • BEAM Beam Therapeutics Inc: other filings, last Jun 4, 2025
  • NGM NGM Biopharmaceuticals Inc: other filings, last Apr 5, 2024

Get free alerts when Carole Ho files a new trade →